TG THERAPEUTICS, INC. Operating Lease Liability
TG THERAPEUTICS, INC. (TGTX) had Operating Lease Liability of $9.05 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Liabilities
us-gaap:OperatingLeaseLiability · last filed 2026-08-05
- 2026-06-30: Operating Lease, Liability $9.05M.
- 2026-03-31: Operating Lease, Liability $8.42M.
- 2025-12-31: Operating Lease, Liability $8.06M.
- 2025-09-30: Operating Lease, Liability $8.38M.
| Period end | Operating Lease, Liability |
|---|---|
| 2026-06-30 | $9.05M 10-Q · filed 2026-08-05 |
| 2026-03-31 | $8.42M 10-Q · filed 2026-05-06 |
| 2025-12-31 | $8.06M 10-Q · filed 2026-08-05 |
| 2025-09-30 | $8.38M 10-Q · filed 2025-11-05 |
| 2025-06-30 | $8.68M 10-Q · filed 2025-08-08 |
| 2025-03-31 | $8.98M 10-Q · filed 2025-05-09 |
| 2024-12-31 | $9.29M 10-K · filed 2026-02-27 |
| 2024-09-30 | $9.65M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $10.00M 10-Q · filed 2024-08-09 |
| 2024-03-31 | $10.34M 10-Q · filed 2024-05-06 |
| 2023-12-31 | $10.68M 10-K · filed 2025-03-03 |
| 2023-09-30 | $11.00M 10-Q · filed 2023-11-06 |
| 2023-06-30 | $11.32M 10-Q · filed 2023-08-04 |
| 2023-03-31 | $11.63M 10-Q · filed 2023-05-08 |
| 2022-12-31 | $11.93M 10-K · filed 2024-02-29 |
| 2022-09-30 | $12.20M 10-Q · filed 2022-11-09 |
| 2022-06-30 | $11.46M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $11.81M 10-Q · filed 2022-05-10 |
| 2021-12-31 | $11.28M 10-K · filed 2023-03-01 |
| 2021-09-30 | $11.49M 10-Q · filed 2021-11-08 |
| 2021-06-30 | $11.69M 10-Q · filed 2021-08-06 |
| 2021-03-31 | $11.88M 10-Q · filed 2021-05-10 |
| 2020-12-31 | $12.08M 10-K · filed 2022-03-01 |
| 2020-09-30 | $11.42M 10-Q · filed 2020-11-09 |
| 2020-06-30 | $11.59M 10-Q · filed 2020-08-10 |
| 2020-03-31 | $11.76M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $11.83M 10-K · filed 2021-03-01 |
| 2019-09-30 | $10.74M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $9.35M 10-Q · filed 2019-08-09 |
| 2019-03-31 | $9.44M 10-Q · filed 2019-05-10 |
| 2018-12-31 | $0.00 10-Q · filed 2019-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |